Madison Avenue Partners, LP

Q4 2024 13F Holdings

  • Location
    new york, NY
  • Num holdings

    15

  • Value ($000)

    $944,370

  • Date Filed
    02/14/2025
  • Form type
    13F-HR
  • CIK
    0001801265
  • All SEC filings
  • Note
    Holdings aggregated across “other managers” listed in original SEC filing, see here for detailed holdings broken out by other managers
Compare Q4 2024 to
Select Quarter
Issuer Name
Class
CUSIP
VALUE
%
Shares
Principal
Option Type
---

GRAHAM HLDGS CO

COM CL B
384637104
$205.14M
22 %

235,271

SOLV
SOLV

SOLVENTUM CORP

COM SHS
83444M101
$186.80M
20 %

2,827,672

WLY
WLY

WILEY JOHN & SONS INC

CL A
968223206
$91.65M
10 %

2,096,793

---

THERAVANCE BIOPHARMA INC

COM
G8807B106
$89.50M
10 %

9,511,150

ACHC
ACHC

ACADIA HEALTHCARE COMPANY INC

COM
00404A109
$76.34M
8 %

1,925,327

EDR
EDR

ENDEAVOR GROUP HLDGS INC

CL A COM
29260Y109
$75.02M
8 %

2,397,658

---

MAGNERA CORP

COM SHS
55939A107
$61.89M
7 %

3,406,293

STGW
STGW

STAGWELL INC

COM CL A
85256A109
$47.03M
5 %

7,147,662

---

INDIVIOR PLC

ORD
G4766E116
$45.66M
5 %

3,673,426

NIJ
NIJ

NELNET INC

CL A
64031N108
$31.00M
3 %

290,213

Rows Per Page
10
  • 10
  • 50
  • 100
1 - 10 of 15